Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: Can they be interconnected?

Pigment Cell Research

Volumn 20, Issue 5, 2007, Pages 360-363

  Namazi, M R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Etiology; Hypotheses; Pathophysiology; Vitiligo

Indexed keywords

AUTOANTIGEN; CATECHOLAMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A; MELANIN; MONOPHENOL MONOOXYGENASE; NORADRENALIN; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; AUTONOMIC NERVE; B LYMPHOCYTE; CATECHOLAMINE RELEASE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL DESTRUCTION; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; EPIDERMIS; HUMAN; HYPOXIA; IMMUNE RESPONSE; MELANOCYTE; NERVE CELL DIFFERENTIATION; NERVE ENDING; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SYNAPSE; VITILIGO;

ANIMALS; AUTOIMMUNE DISEASES; CATALYSIS; CELL ADHESION; EPIDERMIS; GENE EXPRESSION REGULATION; HUMANS; MELANOCYTES; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VITILIGO;

EID: 34548565744     PISSN: 08935785     EISSN: 16000749     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2007.00408.x     Document Type: Article

References (26)

1. Ahn, K.S. Aggarwal, B.B. (2005). Transcription factor NF- kappaB: a sensor for smoke and stress signals. Ann. N. Y. Acad. Sci. 1056, 218 233.
2. Birol, A., Kisa, U., Kurtipek, G.S., Kara, F., Kocak, M., Erkek, E. Caglayan, O. (2006). Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo. Int. J. Dermatol. 45, 992 993.
3. Casiano, C.A. Pacheco, F.J. (2006). Cell death and autoimmunity. In Autoantibodies and Autoimmunity, K.M. Pollard, ed Germany : Willey-VCH Verlag pp. 107 137.
4. Chandel, N.S., Trzyna, W.C., McClintock, D.S. Schumacker, P.T. (2000). Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J. Immunol. 165, 1013 1021.
5. Chaudhri, G., Hunt, N.H., Clark, I.A. Ceredig, R. (1998). Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell. Immunol. 115, 204 213.
6. Fields, R.C., Schoenecker, J.G., Hart, J.P., Hoffman, M.R., Pizzo, S.V. Lawson, J.H. (2003). Protease-activated receptor-2 signaling triggers dendritic cell development. Am. J. Pathol. 162, 1817 1822.
7. Gauthier, Y., Cario Andre, M. Taieb, A. (2003). A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?. Pigment. Cell Res. 16, 322 332.
8. Ghezzi, P., Dinarello, C.A., Bianchi, M., Rosandich, M.E., Repine, J.E. White, C.W. (1991). Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3, 189 194.
9. Grifiths, H.R. (2005). ROS as signalling molecules in T cells- evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox. Rep. 10, 273 280.
10. Huang, C.L., Nordlund, J.J. Boissy, R. (2002). Vitiligo: a manifestation of apoptosis? Am. J. Clin. Dermatol. 3, 301 308.
11. Kannan, S. (2006). Free radical theory of autoimmunity. Theor. Biol. Med. Model. 3, 22.
12. Kurien, B.T., Hensley, K., Bachmann, M. Scofield, R.H. (2006). Oxidatively modified autoantigens in autoimmune diseases. Free Radic. Biol. Med. 41, 549 556.
13. Lang, K.S., Caroli, C.C., Muhm, A., Wernet, D., Moris, A. Schittek, B. (2001). HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J. Invest. Dermatol. 116, 891 897.
14. Martínez, D., Vermeulen, M., von Euw, E. et al. (2007). Extracellular Acidosis Triggers the Maturation of Human Dendritic Cells and the Production of IL-12. J. Immunol. 179, 1950 1959.
15. Martinez-Esparza, M., Jimenez-Cervantes, C. Solano, F. (1998). Mechanisms of melanogenesis inhibition by tumor necrosis factor-α in B16-F10 mouse melanoma cells. Eur. J. Biochem. 255, 139 146.
16. Nagy, G., Koncz, A., Fernandez, D. Perl, A. (2007). Nitric oxide, mitochondrial hyperpolarization, and T cell activation. Free Radic. Biol. Med. 2007, 42.
17. Namazi, M.R. (2003). Prescribing cyclic antidepressants for vitiligo patients: which agents are superior, which are not? Psychother. Psychosom. 72, 361 362.
18. Ogg, G.S., Rod Dunbar, P., Romero, P., Chen, J.L. Cerundolo, V. (1998). High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188, 1203 1208.
19. Passeron, T. Ortonne, J.-P. (2005). Pathophysiology and genetics of vitiligo. J. Autoimmun. 25, 63 68.
20. Santos-Rosa, M., Bienvenu, J. Whiher, J. (1999). Cytokines. In Tietz Textbook of Clinical Chemistry. C.A. Burtis E.R. Ashwood, eds Philadelphia : Saunders) 1999 : 587 592.
21. Schallreuter, K.U., Moore, J. Wood, J.M. 2000). Pseudocatalse in the treatment of vitiligo. In Vitiligo, S.K. Hann J.J. Nordlund eds (Oxford : Blackwell Science pp. 186.
22. Simon, H.U., Haj-Yehia, A. Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415 418.
23. Song, Y.H. (1997). Why tyrosinase for treatment of melanoma? Lancet 350, 82 83.
24. Vahedi Darmian, F., Joubeh, S., Doroudchi, M., Abdollahi, B. Ghaderi, A. (2004). Detection of rheumatoid factors in sera and biopsy lesions of vitiligo patients. Iran J. Immunol. 1, 48 55.
25. Vermeulen, M.E., Gamberale, R., Trevani, A.S., Martínez, D., Ceballos, A., Sabatte, J., Giordano, M. Geffner, J.R. (2004). The impact of extracellular acidosis on dendritic cell function. Crit. Rev. Immunol. 24, 363 384.
26. Westerhof, W. d'Ischia, M. (2007). Vitiligo puzzle: the pieces fall in place. Pigment Cell Res. 20, doi:.